Prof. Marçal Pastor-Anglada, Dr. Sandra Pérez Torras – Molecular Pharmacology and Experimental Therapeutics group (MPET); Departament de Bioquímica i Biomedicina, Faculty of Biology, University of Barcelona
Validation of stimuli-responsive oligonucleotide tools in relevant models of cancer and other complex disorders (e.g. breast cancer).
Bruker Biospin GmbH corporation – Germany
Synthesis and NMR characterization of model therapeutic oligonucleotides (scientific-transfer project signed in April 2024; FBG 312793).
Dr. Alessandro Sorrenti – Non-Equilibrium Supramolecular Self-Assembly (NESSA) Lab; Department of Inorganic and Organic Chemistry (Secció de Química Orgànica), Faculty of Chemistry, University of Barcelona
Application of stimuli-responsive oligonucleotide-based approaches to the development of new supramolecular materials of therapeutic potential.
Dr. Maria Francesca Cortese – Department of Microbiology; VHIR (Vall d’Hebron Institut de Recerca)
Extrapolation of oligonucleotide-based stimuli-responsive muti-targeting approaches to viral pathologies.